4.6 Review

Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI

Farah Deba et al.

Summary: This study investigates the binding and gating properties of CMPI at the alpha 4:alpha 4 interface, providing insights into the functional contributions of ligand binding at this subunit interface to nAChR-channel gating. The findings suggest the potential use of alpha 4:alpha 4 specific ligands to enhance the efficacy of acetylcholine in conditions associated with decline in nAChRs activity in the brain.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Pharmacology & Pharmacy

Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough

Brendan J. Canning et al.

Summary: The study documents the antitussive actions of nicotine and identifies the alpha(7) nicotinic receptor subtype as the target for nicotine during cough suppression in humans. Additionally, evidence suggests that ATA-101 and other alpha(7) nicotinic receptor-selective agonists may be promising candidates for the treatment of chronic refractory cough.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)

Article Pharmacology & Pharmacy

The alpha 9 alpha 10 nicotinic acetylcholine receptor: a compelling drug target for hearing loss?

Ana Belen Elgoyhen

Summary: Hearing loss, which has a significant impact on various aspects of life, lacks effective drugs for prevention or restoration. The alpha 9 alpha 10 nicotinic acetylcholine receptor (nAChR) has the potential to be a novel drug target for preventing noise-induced and age-related hearing loss.

EXPERT OPINION ON THERAPEUTIC TARGETS (2022)

Article Chemistry, Medicinal

Discovery of novel positive allosteric modulators of the α7 nicotinic acetylcholine receptor: Scaffold hopping approach

Istvan Ledneczki et al.

Summary: The paper describes the discovery of a novel nicotinic alpha 7 receptor positive modulator through scaffold hopping, leading to the identification of a promising new chemotype with good physicochemical and in vitro parameters. These compounds showed favorable characteristics in vitro and in vivo evaluations, suggesting the potential to improve cognitive performance.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Pharmacology & Pharmacy

LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization

Mahip K. Verma et al.

Summary: The study introduces a novel alpha 7 nAChR positive allosteric modulator (PAM), LL-00066471, which shows excellent oral bioavailability and potential in symptomatically alleviating cognitive deficits and sensorimotor gating deficits.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Clinical Neurology

The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial

Michael Davidson et al.

Summary: Although positive allosteric modulators can delay receptor desensitization, the results of this study suggest that adding JNJ-39393406 did not significantly improve cognition and depressive symptoms in patients with unipolar depression.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)

Article Clinical Neurology

Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation

Katarzyna M. Targowska-Duda et al.

Summary: This study investigated the antidepressant-like activity induced by type I and type II positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors in mice, revealing a mechanism involving alpha 7 potentiation and activation of mTOR/ERK signaling pathways, without neurotransmitter transporter inhibition. Synergistic effects were observed between certain drugs, supporting potential clinical use of alpha 7-PAMs for depression disorders.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site

Maria Chiara Pismataro et al.

Summary: NS6740 is a selective partial agonist for the alpha(7) nicotinic acetylcholine receptor, capable of promoting stable conversion of receptors to nonconducting states and reactivation with positive allosteric modulators. Despite its low efficacy for channel activation, it is an effective activator of the cholinergic anti-inflammatory pathway. Experimental results suggest that the unique properties of NS6740 may primarily be due to binding at the sites for orthosteric agonists.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Clinical Neurology

(E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by α7 nicotinic acetylcholine receptor potentiation

Deniz Bagdas et al.

Summary: PAM-4, a highly selective alpha 7-nAChR PAM, offers potential for attenuating both sensorial and affective behaviors induced by chronic pain, suggesting its effectiveness in managing chronic painful conditions with comorbidities.

NEUROLOGICAL RESEARCH (2021)

Review Pharmacology & Pharmacy

Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors

Roger L. Papke et al.

Summary: The alpha 7-type nicotinic acetylcholine receptor, with its unique characteristics and potential therapeutic importance, is the focus of research on subtype-selective agonists and conformational landscape. Challenges arise from rapid desensitization and ligand binding sites, but positive allosteric modulators and direct allosteric agonist or antagonists have diverse effects on receptor activation profiles.

PHARMACOLOGICAL REVIEWS (2021)

Article Pharmacology & Pharmacy

Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors

Marloes van Hout et al.

BIOCHEMICAL PHARMACOLOGY (2020)

Review Pharmacology & Pharmacy

Selective α7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia - a review

Kirsten Antonio-Tolentino et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)

Article Behavioral Sciences

Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine by low-dose galantamine in rats

Britta Hahn et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)

Article Biochemistry & Molecular Biology

Molecular interactions of type I and type II positive allosteric modulators with the human 7 nicotinic acetylcholine receptor: an in silico study

Katarzyna M. Targowska-Duda et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)

Article Chemistry, Medicinal

Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs

Andrew J. Harvey et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Article Pharmacology & Pharmacy

Allosteric Agonism of α7 Nicotinic Acetylcholine Receptors: Receptor Modulation Outside the Orthosteric Site

Alican Gulsevin et al.

MOLECULAR PHARMACOLOGY (2019)

Article Pharmacology & Pharmacy

Binding Interactions of NS6740, a Silent Agonist of the α7 Nicotinic Acetylcholine Receptor

Catriona E. W. Blunt et al.

MOLECULAR PHARMACOLOGY (2019)

Article Neurosciences

Flavonoids as positive allosteric modulators of α7 nicotinic receptors

Beatriz Elizabeth Nielsen et al.

NEUROPHARMACOLOGY (2019)

Review Chemistry, Medicinal

Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities

Dina Manetti et al.

FUTURE MEDICINAL CHEMISTRY (2018)

Article Pharmacology & Pharmacy

Curcumin Acts as a Positive Allosteric Modulator ofα7-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain

Eslam Gaber El Nebrisi et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)

Review Pharmacology & Pharmacy

Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors

Jingyi Wang et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Article Pharmacology & Pharmacy

B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor

Debra J. Post-Munson et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2017)

Article Chemistry, Medicinal

The Essential Medicinal Chemistry of Curcumin

Kathryn M. Nelson et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Editorial Material Chemistry, Medicinal

Anti-inflammatory Silent Agonists

Nicole A. Horenstein et al.

ACS MEDICINAL CHEMISTRY LETTERS (2017)

Article Pharmacology & Pharmacy

Allosteric Modulation of Nicotinic Acetylcholine Receptors: The Concept and Therapeutic Trends

Victor V. Uteshev

CURRENT PHARMACEUTICAL DESIGN (2016)

Review Pharmacology & Pharmacy

Allosteric modulation of nicotinic acetylcholine receptors

Anna Chatzidaki et al.

BIOCHEMICAL PHARMACOLOGY (2015)

Article Biochemistry & Molecular Biology

Structurally Similar Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors Exhibit Five Distinct Pharmacological Effects

JasKiran K. Gill-Thind et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Chemistry, Medicinal

Chalcones as positive allosteric modulators of α7 nicotinic acetylcholine receptors: A new target for a privileged structure

Beatriz Balsera et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Pharmacology & Pharmacy

Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES

Maegan M. Weltzin et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Article Pharmacology & Pharmacy

The therapeutic promise of positive allosteric modulation of nicotinic receptors

Victor V. Uteshev

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Article Pharmacology & Pharmacy

Characterization of RO5126946, a Novel α7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator

Sunil Sahdeo et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)

Article Pharmacology & Pharmacy

Positive modulation of the α9α10 nicotinic cholinergic receptor by ascorbic acid

J. C. Boffi et al.

BRITISH JOURNAL OF PHARMACOLOGY (2013)

Article Multidisciplinary Sciences

Stoichiometry for activation of neuronal α7 nicotinic receptors

Natalia Andersen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

Defining the Putative Inhibitory Site for a Selective Negative Allosteric Modulator of Human α4β2 Neuronal Nicotinic Receptors

Brandon J. Henderson et al.

ACS CHEMICAL NEUROSCIENCE (2012)

Article Biochemistry & Molecular Biology

Novel Positive Allosteric Modulators of the Human α7 Nicotinic Acetylcholine Receptor

Hugo R. Arias et al.

BIOCHEMISTRY (2011)

Article Physiology

The effective opening of nicotinic acetylcholine receptors with single agonist binding sites

Dustin K. Williams et al.

JOURNAL OF GENERAL PHYSIOLOGY (2011)

Article Chemistry, Medicinal

Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators

Anatoly A. Mazurov et al.

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

Agonist activation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site

JasKiran K. Gill et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Pharmacology & Pharmacy

Negative Allosteric Modulators That Target Human α4β2 Neuronal Nicotinic Receptors

Brandon J. Henderson et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)

Article Biochemistry & Molecular Biology

Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain

Juergen Ludwig et al.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2010)

Article Neurosciences

In vitro and in vivo characterization of a novel negative allosteric modulator of neuronal nAChRs

Galya R. Abdrakhmanova et al.

NEUROPHARMACOLOGY (2010)

Article Pharmacology & Pharmacy

Alpha9 nicotinic acetylcholine receptors and the treatment of pain

J. Michael McIntosh et al.

BIOCHEMICAL PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Structural and functional diversity of native brain neuronal nicotinic receptors

Cecilia Gotti et al.

BIOCHEMICAL PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Role of channel activation in cognitive enhancement mediated by α7 nicotinic acetylcholine receptors

Clark A. Briggs et al.

BRITISH JOURNAL OF PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Differential Pharmacologies of Mecamylamine Enantiomers: Positive Allosteric Modulation and Noncompetitive Inhibition

Nikolai B. Fedorov et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)

Article Pharmacology & Pharmacy

Effect of Novel Negative Allosteric Modulators of Neuronal Nicotinic Receptors on Cells Expressing Native and Recombinant Nicotinic Receptors: Implications for Drug Discovery

Tatiana F. Gonzalez-Cestari et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)

Review Biotechnology & Applied Microbiology

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

P. Jeffrey Conn et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Review Biotechnology & Applied Microbiology

Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system

Antoine Taly et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Pharmacology & Pharmacy

Conformational changes in alpha 7 acetylcholine receptors underlying allosteric modulation by divalent cations

James T McLaughlin et al.

BMC Pharmacology & Toxicology (2009)

Article Chemistry, Medicinal

Synthesis and activity of substituted carbamates as potentiators of the α4β2 nicotinic acetylcholine receptor

Stephanie K. Springer et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Review Chemistry, Medicinal

Allosteric modulators of the α7 nicotinic acetylcholine receptor

Ramin Faghih et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Pharmacology & Pharmacy

Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine α3β2 receptors

Tse-Yu Wu et al.

MOLECULAR PHARMACOLOGY (2008)

Article Multidisciplinary Sciences

Potentiation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site

Gareth T. Young et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Neurosciences

Ryanodine is a positive modulator of acetylcholine receptor gating in cochlear hair cells

Javier Zorrilla de San Martin et al.

JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY (2007)

Article Pharmacology & Pharmacy

Allosteric modulation of nicotinic acetylcholine receptors

Daniel Bertrand et al.

BIOCHEMICAL PHARMACOLOGY (2007)

Article Pharmacology & Pharmacy

An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo

Daniel B. Timmermann et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)

Article Pharmacology & Pharmacy

Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes

Jens Halvard Gronlien et al.

MOLECULAR PHARMACOLOGY (2007)

Article Chemistry, Medicinal

Synthesis of desformylflustrabromine and its evaluation as an α4β2 and α7 nACh receptor modulator

Jin-Sung Kim et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

Review Chemistry, Medicinal

Central nicotinic receptors: Structure, function, ligands, and therapeutic potential

M. Novella Romanelli et al.

CHEMMEDCHEM (2007)

Article Multidisciplinary Sciences

Nootropic α7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators

Herman J. Ng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Pharmacology & Pharmacy

Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators

Lisa M. Broad et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Article Pharmacology & Pharmacy

Determinants of zinc potentiation on the alpha 4 subunit of neuronal nicotinic receptors

B Hsiao et al.

MOLECULAR PHARMACOLOGY (2006)

Review Biochemistry & Molecular Biology

Selective alpha 7 nicotinic acetylcholine receptor ligands

Anatoly Mazurov et al.

CURRENT MEDICINAL CHEMISTRY (2006)

Review Neurosciences

Desensitized nicotinic receptors in brain

H Wang et al.

BRAIN RESEARCH REVIEWS (2005)

Article Pharmacology & Pharmacy

Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors

ME Nelson et al.

MOLECULAR PHARMACOLOGY (2003)

Review Neurosciences

Desensitization of neuronal nicotinic receptors

MW Quick et al.

JOURNAL OF NEUROBIOLOGY (2002)

Article Cell Biology

Permeant but not impermeant divalent cations enhance activation of nondesensitizing α7 nicotinic receptors

D Eddins et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)

Review Pharmacology & Pharmacy

Nicotine addiction: the possible role of functional upregulation

B Buisson et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2002)

Article Neurosciences

Subunit-dependent modulation of neuronal nicotinic receptors by zinc

B Hsiao et al.

JOURNAL OF NEUROSCIENCE (2001)

Article Pharmacology & Pharmacy

α7 receptor-selective agonists and modes of α7 receptor activation

RL Papke et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2000)